Cappello Joseph 4
4 · GENELUX Corp · Filed May 13, 2025
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Cappello Joseph
VP, Pharmaceutical Development
Transactions
- Sale
Common Stock
2025-05-12$2.92/sh−4,737$13,832→ 52,266 total
Footnotes (1)
- [F1]Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units.